Pharmafile Logo

Kraeber (UK) Ltd

The family owned business, Kraeber & Co GmbH, is an independent, technology based enterprise which was founded on the 1st January 1980 in Hamburg. Hanseatic tradition together with courageous entrepreneurship characterize our company. We are committed to open and global competition which we stand up with our service capabilities. Our emphasis is the development, production, marketing and sales of active pharmaceutical ingredients (APIs) of the highest purity. Kraeber has evolved into a niche marketer and supplier. By continously innovating productions, we became the quality market leader in Europe and in other parts of the world for many of our products.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

16 The Street, Saxon Street, Newmarket, Suffolk, CB8 9RU, United Kingdom
+44 (0)1638 731 297

 Latest Content from PMHub 

VuuAI and Amiculum partner to transform content engagement in pharma

Press Releases | December 2, 2025 | Amiculum

Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation platform. The collaboration is designed to optimize the deployment of...

From overwhelming to actionable: Bringing lifestyle guidance to life

Discover how clear communication and health literacy principles can transform complex patient materials into simple, engaging, and empowering health information.

5 key digital CX challenges in pharma, and how to start solving them

Press Releases | December 2, 2025 | Graphite Digital

Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

Press Releases | December 1, 2025 | Medscape Education

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Behind the scenes: why we created ‘The participation equation’

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.

Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025

Press Releases | November 28, 2025 | Inizio

As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...

Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success

Press Releases | November 27, 2025 | Cuttsy + Cuttsy

Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.

How DataGateway unified oncology data for real-world insights & market intelligence

Press Releases | November 26, 2025 | Inizio

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Press Releases | November 26, 2025 | Inizio

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.